Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.

Date publication

août 2020

Journal

American heart journal

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick

Tous les auteurs :
Elharram M, Sharma A, White W, Bakris G, Rossignol P, Mehta C, Ferreira JP, Zannad F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32916607

Résumé

The timing of enrolment following an acute coronary syndrome (ACS) may influence cardiovascular (CV) outcomes and potentially treatment effect in clinical trials. Understanding the timing and type of clinical events after an ACS will allow for clinicians to better tailor evidence-based treatments to optimize therapeutic effect. Using a large contemporary trial in patients with type 2 diabetes mellitus (T2DM) post-ACS, we examined the impact of timing of enrolment on subsequent CV outcomes.

Référence

Am. Heart J.. 2020 Aug 6;229:40-51